NCT02291510View on ClinicalTrials.gov

Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy Subjects
Interventions
DRUG

Met DR

metformin delayed-release tablets

DRUG

Met XR

metformin extended-release tablets

DRUG

Met IR

metformin immediate-release tablets

Sponsors
All Listed Sponsors
lead

Elcelyx Therapeutics, Inc.

INDUSTRY